期刊文献+

Ezrin、c-Met和CD44v6在胃癌中的表达及其相关性 被引量:3

Expression and relationship of Ezrin、c-Met and CD44v6 in gastric cancer
下载PDF
导出
摘要 目的探讨Ezrin、c-Met和CD44v6在胃癌中的表达情况,分析其相关性以及与胃癌生物学特性的关系。方法采用免疫组织化学方法检测Ezrin、c-Met和CD44v6在130例胃癌组织中的表达情况。结果 130例胃癌组织中Ezrin阳性表达率为61.0%;c-Met阳性表达率为58.0%;CD44v6阳性表达率为53.0%。Ezrin和CD44v6的表达情况与临床分期、淋巴结转移以及TNM分期有关(P<0.05);c-Met的表达与浸润深度、淋巴结转移以及TNM分期有关(P<0.05)。胃癌组织中Ezrin分别与c-Met、CD44v6表达水平呈正相关,且c-Met与CD44v6表达呈正相关(P<0.05)。结论 Ezrin和肿瘤转移相关分子c-Met、CD44v6可能在胃癌浸润转移中起着协同作用,联合检测其表达情况可为胃癌侵袭转移的监测以及治疗和判断其预后提供新的依据。 Objective To investigate the expression, relationship and tumor biology characters between Ezrin, c-Met and CD44v6 in gastric cancer. Methods The expression of Ezrin, c- Met and CD44v6 of gastric cancer samples from 130 patients was analyzed by immunohisto- chemistry. Results Ezrin was expressed in 61.0% of 130 gastric cancer samples. High levels expression of c-Met and CD44v6 were found in 58.0% and 53.0% of tumors samples respec- tively. Ezrin expression exhibited a positive correlation with c-Met and CD44v6 expression, and CD44v6 expression was positively correlated with the expression of c-Met (P 〈 0. 05 ). Positive expression of Ezrin and CD44v6 were significantly associated with tumor stage, lymph node me- tastasis and TNM stage (P 〈 0. 05 ). C-Met expression was correlated with invasion depth, lymph node metastasis and TNM stage. Conclusion Ezrin,c-Met and CD44v6 are tumor me- tastasis-associated markers that have synergistic effect in gastric cancer infiltration and metasta- sis. Combined analysis of these molecules may offer new useful information on invasion, metas- tasis, speculated prognosis and therapy.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2013年第1期67-70,共4页 Journal of Harbin Medical University
关键词 EZRIN C-MET CD44V6 胃癌 侵袭转移 Ezrin c-Met CD44v6 gastric cancer invasion and metastasis
  • 相关文献

参考文献13

  • 1Fehon RG, McClatchey AI, Bretscher A, et al. Organizing the cell cortex: the role of ERM proteins[ J]. Nat Rev Mol Cell Biol, 2010,11 (4) :276-287.
  • 2Hunter KW. Ezrin, a key component in tumor metastasis [ J ]. Trends Mol Med, 2004,10(5) :201-204.
  • 3Kobel M, Gradhand E, Zeng K, et al. Ezrin promotes ovarian car- cinoma cell invasion and its retained expression predicts poor prog- nosis in ovarian carcinoma [ J ]. Int J Gynecol Pathol, 2006,25 (2) :121-130.
  • 4Valdman A, Fang X, Pang ST, et al. Ezrin expression in prostate cancer and benign prostatic tissue [ J ]. Eur Urol, 2005,48 ( 5 ) : 852-857.
  • 5Boldrini E, Peres SV, Morini S, et al. Immunoexpression of Ezrin and CD44 in patients with osteosarcoma [ J ]. J Pediatr Hematol Oncol, 2010,32(6) :213-217.
  • 6Saotome 1, Curto M, MeClatehey AI. Ezrin is essential for epithe- lial organization and villus morphogenesis in the developing intes- tine[J]. Dev Cell, 2004,6(6) :855-864.
  • 7Meng Y, Lu Z, Yu S, et al. Ezrin promotes invasion and metasta- sis of pancreatic cancer cells[J]. J Transl Med, 2010, 8:61-75.
  • 8Benvenuti S, Comoglio PM. The MET receptor tyrosine kinase in invasion and metastasis[J]. J Cell Physiol, 2007,213(2) :316- 325.
  • 9Bu R, Uddin S, Bavi P, et al. HGF/c-Met pathway has a promi- nent role in mediating antiapoptotic signals through AKT in epithe- lial ovarian carcinoma[ J]. Nature, 2011,91 ( 1 ) : 124-137.
  • 10Chuan YC, Iglesias-Gato D, Fernandez-Perez L, et al. Ezrin mediates e-Myc actions in prostate cancer cell invasion [ J ]. On- cogene, 2010,29(10) :1531-1542.

同被引文献53

  • 1魏伟,吴希美,李元健.药理学实验方法学[M].4版.北京:人民卫生出版社,2010:1063-1088.
  • 2孙燕,石远凯.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2012:476-491.
  • 3Biedler JL,Riehm H.Cellular resistance to actinomycin D in Chinese hamster cells in vitro:cross-resistance,radioautographic,and cytogenetic studies[J].Cancer Res,1970,30(4):1174-1184.
  • 4Yoo BK,Chen D,Su ZZ,et al.Molecular mechanism of chemoresistance by astrocyte elevated gene-1[J].Cancer Res,2010,70(8):3249-3258.
  • 5Saigusa S,Inoue Y,Tanaka K,et al.Significant correlation between LKB1 and LGR5 gene expression and the association with poor recurrence-free survival in rectal cancer after preoperative chemo-radiotherapy[J].J Cancer Res Clin Oncol,2013,139(1):131-138.
  • 6Xia J,Wu Z,Yu C,et al.miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1[J].J Pathol,2012,227(4):470-480.
  • 7Tsubaki M,Satou T,Itoh T,et al.Overexpression of MDR1 and survivin and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells[J].Leuk Res,2012,36(10):1315-1322.
  • 8Lin CF,Chen CL,Lin YS.Ceramide in apoptotic signaling and anticancer therapy[J].Curr Med Chem,2006,13(14):1609-1616.
  • 9Otaka M,Odashima M,Izumi Y,et al.Target molecules of molecular chaperone(HSP70family) in injured gastric mucosa in vivo[J].Life Sci,2009,84(19/20):664-667.
  • 10Rohwer N,Cramer T.Hypoxia-meditaed drug resistance:novel insights on the functional interaction of HIFs and cell death pathways[J].Drug Resist Updat,2011,14(3):191-201.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部